[1]
Gupta, Y. et al. 2024. Bilirubin Nanomedicines for the Treatment of Reactive Oxygen Species (ROS)-Mediated Diseases. Journal for Research in Applied Sciences and Biotechnology. 3, 1 (Feb. 2024), 154–158. DOI:https://doi.org/10.55544/jrasb.3.1.25.